Table 1 Baseline differences in subjects by CVD status
Trait | No CVD (n = 364) | CVD (n = 188) | P Value |
|---|---|---|---|
Age (years) | 65.5 (11.3) | 69.6 (9.6) | <0.001 |
Duration (years)+ | 8 (4–15) | 10 (5.5–17) | 0.008 |
Systolic blood pressure (mmHg)* | 141 (128–153) | 139 (129–154) | 0.340 |
Diastolic blood pressure (mmHg)* | 81 (74–87) | 76 (71–83) | 0.004 |
Body mass index (kg/m2)* | 29.17 (26.23–32.58) | 29.08 (26.13–31.97) | 0.262 |
HbA1c (%)* | 7.6 (6.6–8.9) | 7.4 (6.5–8.7) | 0.336 |
Creatinine (mmol/l)* | 88 (76–103) | 99 (84–122) | <0.001 |
CRP (mg/l)*; | 1.73 (1.06–3.18) | 1.80 (0.99–3.34) | 0.578 |
TAOS | 42.50 (13.01) | 41.83 (13.61) | 0.578 |
Sex (F/M) | 165/199 (45.3/54.7%) | 57/131 (30.5/69.5%) | 0.001 |
Normo/micro/proteinuria | 201/128/35 (55.2/35.3/9.5%) | 83/75/30 (44.1/39.9/16.0%) | 0.019 |
Genotype distribution | 155/165/44 (42.6/45.3/12.1%) | 80/85/23 (42.6/45.2/12.2%) | 0.999 |
ACEI (No/Yes) | 197/167 (54.0/46.0%) | 79/109 (42/58%) | 0.008 |
Aspirin (No/Yes) | 215/149 (59.2/40.8%) | 50/138 (26.7/73.3%) | <0.001 |
Insulin (No/Yes) | 280/84 (76.8/23.2%) | 130/58 (69.1/30.9%) | 0.052 |
Statin (No/Yes) | 289/75 (79.3/20.7%) | 85/103 (45.2/54.8%) | <0.001 |